Goater Jeff's Form 4 filing
Surface Oncology, Inc. (SURF) · filed Jan 14, 2022
- Accession no.
- 0001209191-22-003400
- Filed
- Jan 14, 2022
- Trade date
- Jul 21, 2021
- Filing delay
- 177 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $779.4K. It was filed 177 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goater JeffCIK 0001656435 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2021 | Common Stock | SSaleDisposed | −127,778 | $6.10 | −$779,445.8 | 129,222 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.